Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL +2.25%72 Days Payable is 34.88 as of Mar. 2026, which is 4% below its 10-year median of 36.41. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,581.86 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks worse than 71.88% on this metric.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Days Payable or its related term are showing as below:
ISX:HEAL'
s Days Payable Range Over the Past 10 Years
Min: 31.21 Med: 36.41 Max: 40.28
Current: 32.57
During the past 11 years, PT Medikaloka Hermina Tbk's highest Days Payable was 40.28. The lowest was 31.21. And the median was 36.41.
ISX:HEAL's Days Payable is ranked worse than 71.88% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.32
vs ISX:HEAL: 32.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Days Payable falls into.
PT Medikaloka Hermina Tbk Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Medikaloka Hermina Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Days Payable of 34.88 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is near median its historical median of 36.41. Over the past decade, PT Medikaloka Hermina Tbk's Days Payable has ranged from 31.21 to 40.28. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #437 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 71.9%.
Is PT Medikaloka Hermina Tbk's Days Payable too high?
PT Medikaloka Hermina Tbk's current Days Payable of 34.88 is near median its 10-year median of 36.41. Over the past 10 years, this metric has ranged from a low of 31.21 to a high of 40.28. The Healthcare Providers & Services industry median Days Payable is 57.32. PT Medikaloka Hermina Tbk's value of 34.88 is 39.1% below this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #437 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #437 out of 608 companies for Days Payable. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median Days Payable is 57.32. PT Medikaloka Hermina Tbk's value of 34.88 is 39.1% below this benchmark. Historically, PT Medikaloka Hermina Tbk's own Days Payable has ranged from 31.21 to 40.28 over the past decade. While the company's 10-year median is 36.41 vs. the industry median of 57.32, PT Medikaloka Hermina Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.32, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Days Payable of 34.88 is 39.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Days Payable is 34.88, which is near median its own 10-year median of 36.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,581.86, compared to a current price of Rp910.00 — trading 42.5% below its estimated fair value. The current Days Payable is 34.88, which is near median its 10-year median of 36.41 and 39.1% below the Healthcare Providers & Services industry median of 57.32. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Days Payable is 34.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp910.00 is trading 42.5% below its estimated GF Value™ of Rp1,581.86.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Days Payable: 34.88 (near median its 10-year median of 36.41)
GF Value™: Rp1,581.86 vs. price of Rp910.00 (42.5% below fair value)
Industry Position: 39.1% below the Healthcare Providers & Services median (#437 of 608)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
